Researchers created a new kind of cancer drug that can grab a mutant protein while also carrying a second hit against the ...

Physicians stand to earn big money when signing up patients for drug trials. And lately, some of those trials have been ...

Early access to new cancer drugs, granted accelerated approval by the U.S. Food and Drug Administration (FDA), has provided ...

The F.D.A. approved Merck’s injected version of its blockbuster infusion Keytruda. The company says it will be quicker and easier, but it stands to slow the adoption of cheaper competitors and ...

The latest update is out from Shanghai Fudan Zhangjiang Bio Pharmaceutical Co ( ($HK:1349) ). Shanghai Fudan-Zhangjiang Bio-Pharmaceutical has ...

Learn about the clinical trials and research at MSK that led to 11 FDA approvals in 2025, expanding treatment options for a range of different cancers.

Patients can now receive treatment in as little as one to two minutes, compared to a 30-minute IV infusion New option offers greater convenience and flexibility in treatment settings, from hospitals ...

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's Enhertu in combination with Roche ...

Diabetes drugs may be doing more than managing blood sugar, they could also shape cancer biology in unexpected ways.

Ellen Coopersmith rows across the Lake in Central Park. Now that she is retired from her job as a kindergarten teacher, she enjoys spending extra time in New York City when she comes to MSK for her ...

AstraZeneca said on Monday that a late‑stage trial testing its blockbuster therapy Imfinzi in combination with its ...

The Centers for Medicare & Medicaid Services released details of its proposal to address the expensive costs of Medicare Part ...